Disease Doctors Pharmacy Testimonials 
Drug & Device Law
JULY 24, 2023
the relationship between [plaintiff] and its pharmacy benefit manager. . . Apparently, massive loss of evidence was merely a “usual and customary service” of pharmacy benefit mangers nationwide. According to Plaintiffs’ expert. . ., is typical of such relationships in the United States, and it includes usual and customary services.
Drug & Device Law
DECEMBER 29, 2023
Infectious Diseases Society of America , 86 F.4th 2023) (remote trial testimony cannot be compelled beyond Rule 45’s 100-mile limit on subpoenas) ( here ); Carson v. They excluded bogus expert testimony under Fed. Adequate directions for use were something given to doctors by manufacturers, not by doctors to anyone else.
Expert insights. Personalized for you.
52 
Let's personalize your content